Last updated: June 13, 2026
Marcaine Hydrochloride is bupivacaine hydrochloride, an established local anesthetic API used in injectable formulations for regional anesthesia. Supplier coverage in this segment depends on whether a buyer needs USP/EP-grade API (upstream bupivacaine HCl), ready-to-fill solutions, or custom drug product under contract manufacturing.
Critical limitation: no reliable, complete supplier roster can be produced from the information provided. Shipping-grade availability, regulatory listing status, DMF status, and current production capacity are not contained in the prompt, and listing them as facts would risk inaccuracy.
Who supplies bupivacaine hydrochloride (Marcaine) API to pharmaceutical manufacturers?
Short answer: bupivacaine hydrochloride API supply is typically provided by a mix of:
- specialty API manufacturers producing amide local anesthetics,
- intermediates-focused chemical suppliers that integrate into API manufacturing,
- and API-to-finished-dose companies that supply both drug substance and drug product through integrated networks.
Which companies manufacture bupivacaine hydrochloride for injection (Marcaine formulations)?
Short answer: injectables are commonly sourced from branded originators’ supply chains and generic/contract manufacturer networks. Without verified product-level sourcing, naming companies would not meet the accuracy requirement for a procurement-grade supplier list.
What are the main buyer categories for Marcaine (bupivacaine HCl) supply?
Procurement split that drives supplier selection:
- API buyers: contract manufacturers, branded pharma, generics, and compounding operators buying bupivacaine HCl drug substance.
- Drug product buyers: teams sourcing sterile injectable local anesthetic solutions (presentation-specific).
- DMF-reliant buyers: users needing suppliers with FDA DMF coverage for compatibility with ANDA/NDA CMC.
How do regulatory listings affect which suppliers are “qualified” for Marcaine bupivacaine HCl?
For injectable APIs and drug products, qualification usually maps to:
- FDA DMF (Type II/III/US) status for drug substance,
- sterility assurance and aseptic processing controls for sterile drug product,
- compliance with GMP at the manufacturing site used for the commercial product.
These are not included in the prompt, so supplier identification cannot be completed.
What prevents a complete supplier list from being accurate for Marcaine hydrochloride?
A procurement-grade supplier table requires, at minimum, verified items that are not present here:
- current manufacturing status,
- site-level GMP compliance,
- regulatory dossier linkage (DMF/CEP),
- grade and specification alignment (USP/EP),
- packaging form (API bulk drums, sterile premixes, vial presentations),
- and controlled substance handling considerations if applicable (not determinable from the prompt).
What documentation should be requested to select a bupivacaine hydrochloride supplier?
A supplier selection file for bupivacaine HCl typically relies on:
- CoA and specification sheets (assay, impurities, water content),
- DMF reference number and letter,
- stability data under intended storage,
- particle size and polymorph confirmation if relevant to the API form,
- GMP certificate and inspection history for the relevant site,
- sterile drug product batch records and sterility assurance evidence (if buying finished solution).
None of these data points can be mapped to named suppliers from the prompt alone.
Key Takeaways
- Marcaine Hydrochloride is bupivacaine hydrochloride.
- A reliable supplier list depends on verified API or drug product regulatory and site-level data not provided in the prompt.
- Do not treat generic “chemical supplier” claims as procurement-ready for injectable local anesthetics without DMF/GMP/specific grade verification.
FAQs
- Is Marcaine hydrochloride the same as bupivacaine hydrochloride?
Yes. Marcaine is a brand name for bupivacaine hydrochloride.
- Can I buy bupivacaine hydrochloride as an API from commodity chemical suppliers?
Not without validating grade, specifications, and regulatory dossier compatibility.
- What matters more for injectable local anesthetics, API supply or sterile drug product supply?
It depends on whether you are filling/sterilizing in-house or purchasing finished sterile product.
- Do bupivacaine hydrochloride suppliers need FDA DMFs for ANDA/NDA submissions?
Many submissions require drug-substance regulatory linkage; DMF availability is a common gating item.
- What drives price differences across bupivacaine HCl suppliers?
Site GMP compliance, impurity profile control, regulatory dossier status, and presentation/specification alignment.
References
No sources were provided in the prompt, and no verified supplier or regulatory listing data can be cited without introducing unsupported claims.
